Dell to take over InSite One
Dell said the combination of InSite One’s cloud-based, vendor-neutral archive software and storage services with Dell’s Unified Clinical Archive solution will simplify data retention and let medical professionals
Australia-based Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a transaction valued at up to $2.35bn, combining Telix’s operations with ITM’s radioisotope production business and late-stage treatment candidate ITM-11.
The preclinical collaboration is being conducted with Marina Konopleva, associate professor in the Department of Leukemia at MD Anderson Cancer Center. The research collaboration will focus on characterizing